Finasteride
Who holds supplier records for Finasteride? 10 organisations hold a current record for Finasteride: an active US FDA Type II Drug Master File or a CEP. A further 3 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability (10 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (7), China (1), Italy (1) and Spain (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Finasteride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/finasteride
Reading the evidence
- 10 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
7 of the 10 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 9 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (10)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Finasteride. Country is the organisation's recorded country, not necessarily the manufacturing site.
- Dr. Reddy's Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 20521, 43732, 16010 · latest filing Mar 2026
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 19308 · latest filing Mar 2006
- Cipla LimitedIndiaCEP Company GMP cert on recordActive DMF 17680, 15778 · latest filing Sept 2004
- Hetero Labs LimitedIndiaCEP Company GMP cert on recordActive DMF 20893 · latest filing Sept 2007
- Hubei Gedian Humanwell Pharmaceutical Co. LtdChinaCEP Company GMP cert on recordActive DMF 25056 · latest filing Jun 2011
- MSN Laboratories Private LimitedIndiaCEP Company GMP cert on recordActive DMF 21276 · latest filing Jan 2008
- STERLING SPAItalyCEP Company GMP cert on recordActive DMF 18483 · latest filing Jul 2005
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 21300 · latest filing Jan 2008
- SpainCEP Company GMP cert on record
- SHAKTI LIFESCIENCE PRIVATE LIMITEDIndiaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (10)
Certificates of Suitability on the EDQM register for Finasteride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou | CN | CEP 2013-238 - Rev 02 Finasteride, Micronised and non-micronised | Sept 2026 | Inspected Nov 2023 Germany |
| DR. REDDY'S LABORATORIES LIMITED Hyderabad | IN | CEP 2026-197 - Rev 00 Finasteride, Form I | Sept 2026 | — |
| HETERO LABS LIMITED Hyderabad | IN | CEP 2026-263 - Rev 00 Finasteride, Process-II | Aug 2026 | — |
| STERLING S.p.A. Corciano | IT | CEP 2025-142 - Rev 00 Finasteride, code 202426 | Jun 2026 | Inspected Dec 2025 Italy |
| SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai | IN | CEP 2023-335 - Rev 00 Finasteride | Feb 2026 | — |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2016-219 - Rev 02 Finasteride, EAA route | Sept 2024 | — |
| CIPLA LIMITED Mumbai | IN | R1-CEP 2005-025 - Rev 05 Finasteride | Apr 2022 | — |
| CURIA SPAIN S.A.U. Boecillo | ES | R1-CEP 2011-043 - Rev 01 Finasteride, Process A | Aug 2021 | — |
| MSN LABORATORIES PRIVATE LIMITED Rudraram Village | IN | R1-CEP 2008-024 - Rev 04 Finasteride | Aug 2019 | — |
| STERLING S.p.A. Solomeo Di Corciano | IT | R1-CEP 2008-130 - Rev 01 Finasteride | Dec 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (3)
Organisations whose Type II DMFs for Finasteride are no longer active. These show a past filing, not current supply.
Show all 3 historical records
- YUAN XINYANInactive DMF 22675 · filed May 2009
- CRYSTAL PHARMA SAUInactive DMF 18551 · filed Jul 2005
- Hungary · Inactive DMF 17575 · filed Jul 2004
Overview
Finasteride is a 5α-reductase inhibitor used primarily to treat benign prostatic hyperplasia and male pattern baldness by reducing dihydrotestosterone levels.
Chemical identity
- IUPAC name
- (1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide
- Canonical SMILES
- C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2C(=O)NC(C)(C)C)CC[C@@H]4[C@@]3(C=CC(=O)N4)C
- InChIKey
- DBEPLOCGEIEOCV-FXUDXRNXSA-N
- Synonyms
- Propecia API
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- 5-alpha Reductase Inhibitor
- Mechanism of action
- 5-alpha Reductase Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Finasteride?
10 organisations hold an active US FDA Type II Drug Master File or a CEP for Finasteride: Dr. Reddy's Laboratories Ltd. (India), APITORIA PHARMA PRIVATE LTD (India), Cipla Limited (India), Hetero Labs Limited (India), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (China), MSN Laboratories Private Limited (India), STERLING SPA (Italy) and Sun Pharmaceutical Industries Limited (India), and 2 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Finasteride Drug Master Files are active?
Dr. Reddy's Laboratories Ltd. (DMF 20521, 43732), APITORIA PHARMA PRIVATE LTD (DMF 19308), Cipla Limited (DMF 17680, 15778), Hetero Labs Limited (DMF 20893), Hubei Gedian Humanwell Pharmaceutical Co. Ltd (DMF 25056), MSN Laboratories Private Limited (DMF 21276), STERLING SPA (DMF 18483) and Sun Pharmaceutical Industries Limited (DMF 21300). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Finasteride records mean?
3 organisations have only inactive Type II DMFs for Finasteride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Finasteride have a European Certificate of Suitability?
Yes. 9 organisations hold a valid CEP for Finasteride on the EDQM register, including HUBEI GEDIAN HUMANWELL PHARMACEUTICAL CO., LTD. Ezhou (CN), DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN), HETERO LABS LIMITED Hyderabad (IN), STERLING S.p.A. Corciano (IT), SHAKTI LIFESCIENCE PRIVATE LIMITED Mumbai (IN) and APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and 4 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Finasteride supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Finasteride?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.